List of Figures
1.2 List of Figures
Figure 1: Uveitis Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products for the Treatment of Uveitis 31
Figure 2: Uveitis Therapeutics Market, Global, Pipeline, 2017 34
Figure 3: Uveitis Therapeutics Market, Global, Pipeline by Molecular Target, 2017 35
Figure 4: Uveitis Therapeutics Market, APAC, DE-109/Opsiria Market ($m), 2019-2023 37
Figure 5: Uveitis Market, Comparative Efficacy and Safety Heatmap for Pipeline Products 39
Figure 6: Uveitis Therapeutics Market, Competitor Matrix for Uveitis Marketed and Pipeline Products, 2017 40
Figure 7: Uveitis Therapeutics, Global, Average Clinical Trial Failure Rate (%), 2006-2016 43
Figure 8: Uveitis Therapeutics, Global, Clinical Trial Failure Rates by Molecule Type (%), 2006-2016 44
Figure 9: Uveitis Therapeutics, Global, Clinical Trial Failure Rates by Molecular Target (%), 2006-2016 45
Figure 10: Uveitis Therapeutics, Global, Clinical Trial Size per Product by Molecule Type (participants), 2006-2016 46
Figure 11: Uveitis Therapeutics, Global, Clinical Trial Size per Product by Molecular Target (participants), 2006-2016 47
Figure 12: Uveitis Therapeutics, Global, Clinical Trial Size per Trial by Molecule Type (participants), 2006-2016 48
Figure 13: Uveitis Therapeutics, Global, Clinical Trial Size per Trial by Molecular Target (participants), 2006-2016 49
Figure 14: Uveitis Therapeutics, Global, Clinical Trial Duration by Molecule Type (months), 2006-2016 50
Figure 15: Uveitis Therapeutics, Global, Clinical Trial Duration by Molecular Target (months), 2006-2016 51
Figure 16: Uveitis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 52
Figure 17: Uveitis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 52
Figure 18: Uveitis Therapeutics Market, APAC, Treatment Patterns (?000), 2016-2023 54
Figure 19: Uveitis Therapeutics Market, APAC, Market Size ($m), 2016-2023 55
Figure 20: Uveitis Therapeutics Market, India, Treatment Patterns (?000), 2016-2023 56
Figure 21: Uveitis Therapeutics Market, India, Annual Cost of Therapy ($), 2016-2023 57
Figure 22: Uveitis Therapeutics Market, India, Market Size ($m), 2016-2023 58
Figure 23: Uveitis Therapeutics Market, China, Treatment Patterns (?000), 2016-2023 59
Figure 24: Uveitis Therapeutics Market, China, Annual Cost of Therapy ($), 2016-2023 60
Figure 25: Uveitis Therapeutics Market, China, Market Size ($m), 2016-2023 61
Figure 26: Uveitis Therapeutics Market, Australia, Treatment Patterns (?000), 2016-2023 62
Figure 27: Uveitis Therapeutics Market, Australia, Annual Cost of Therapy ($), 2016-2023 63
Figure 28: Uveitis Therapeutics Market, Australia, Market Size ($m), 2016-2023 64
Figure 29: Uveitis Therapeutics Market, South Korea, Treatment Patterns (?000), 2016-2023 65
Figure 30: Uveitis Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2016-2023 66
Figure 31: Uveitis Therapeutics Market, South Korea, Market Size ($m), 2016-2023 67
Figure 32: Uveitis Therapeutics Market, Japan, Treatment Patterns (?000), 2016-2023 68
Figure 33: Uveitis Therapeutics Market, Japan, Annual Cost of Therapy ($), 2016-2023 69
Figure 34: Uveitis Therapeutics Market, Japan, Market Size ($m), 2016-2023 70
Figure 35: Uveitis Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2006-2017 73
Figure 36: Uveitis Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2006-2017 74
Figure 37: Uveitis Therapeutics Market, Global, Licensing Deals by Molecule Type and Stage of Development, 2006-2017 75
Figure 38: Uveitis Therapeutics, Global, Licensing Deals by Molecular Targets and Aggregate Deal Value ($), 2006-2017 76

 

List of Tables
1.1 List of Tables
Table 1: Uveitis Therapeutics Market, APAC, Anatomic Classification of Uveitis 9
Table 2: Uveitis Therapeutics Market, APAC, Definition of Onset, Duration and Course of Uveitis 10
Table 3: Uveitis Therapeutics, APAC, Diseases Most Frequently Associated with Uveitis 13
Table 4: Uveitis Therapeutics, APAC, Investigations for Systemic Conditions Causing Uveitis 15
Table 5: Uveitis Therapeutics Market, APAC, Prognosis for Uveitis Patients 16
Table 6: Uveitis Therapeutics Market, Global, Licensing Deals with Disclosed Deal Value, 2006-2017 77
Table 7: Uveitis Therapeutics Market, Global, All Pipeline Products, Discovery, 2017 78
Table 8: Uveitis Therapeutics Market, Global, All Pipeline Products, Preclinical, 2017 78
Table 9: Uveitis Therapeutics Market, Global, All Pipeline Products, IND/CTA-filed, 2017 79
Table 10: Uveitis, Global, All Pipeline Products, Phase I, 2017 79
Table 11: Uveitis Therapeutics Market, Global, All Pipeline Products, Phase II, 2017 80
Table 12: Uveitis Therapeutics Market, Global, All Pipeline Products, Phase III, 2017 80
Table 13: Uveitis Therapeutics Market, Global, All Pipeline Products, Pre-registration, 2017 80
Table 14: Uveitis Therapeutics Market, Asia-Pacific, Market Forecast, 2016-2023 81
Table 15: Uveitis Therapeutics Market, India, Market Forecast, 2016-2023 81
Table 16: Uveitis Therapeutics Market, China, Market Forecast, 2016-2023 81
Table 17: Uveitis Therapeutics Market, Australia, Market Forecast, 2016-2023 82
Table 18: Uveitis Therapeutics Market, South Korea, Market Forecast, 2016-2023 82
Table 19: Uveitis Therapeutics Market, Japan, Market Forecast, 2016-2023 83